The Department of Health will amend the Code of Practice for Licensed Private Healthcare Institutions, requiring injectable and infusion products used in institutions to fall into three categories: registered or exempted medicinal products, human organ or tissue products, and medical devices listed by MDACS. The code is planned to be gazetted in the fourth quarter of this year and take effect one month after gazettal, while the MDACS-related requirements will take effect on 1 March next year.
Why read this: The content sets out three permitted categories of products, phased effective dates and licensing requirements for beauty parlours providing medical services, allowing licensees and the industry to check their own arrangements.
Kai Tak Hospital will begin providing services in phases from next Monday, with the first phase covering the specialist outpatient building, oncology building and family medicine integrated centre, offering about 250 consultation slots per day initially. Specialist outpatient clinics in internal medicine, surgery, neurosurgery and clinical oncology at Queen Mary Hospital will transfer in batches from late October. Inpatient, surgical and accident and emergency services form the second phase and are expected to come into service in 2028. Kai Tak Hospital is Hong Kong's largest public hospital, with 2,400 beds and a service coverage of 1.8 million people.
Why read this: The announcement sets out the scope of first-phase services and the transfer timetable, and includes figures on Kai Tak Hospital's bed capacity and population covered, allowing readers to verify when related services at Queen Mary Hospital will move.